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Aim:  The  aim  of  this  study  was to  evaluate  the  diagnostic  accuracy  of  soluble  triggering
receptor  expressed  on myeloid  cells-1  (sTREM-1)  in  comparison  to procalcitonin  (PCT)
and  C-reactive  protein  (CRP)  in  early  diagnosis  of  septic  meningitis  and  its usefulness  to
distinguish  between  septic  and aseptic  meningitis.
Patients and  methods:  This  study  included  26  patients  with  septic  meningitis,  32  patients
with  aseptic  meningitis  and 15  controls.  Besides  Gram  staining,  cultures  of  blood  and  CSF
and latex  agglutination  test  of CSF,  CRP,  serum  PCT and  sTREM-1  measurement  were  done
on admission  and  after  48–72  h  of  treatment.
Results:  Septic  meningitis  was diagnosed  in 26  (44.82%)  of  the  studied  cases.  Patients  with
septic  meningitis  had  a signiﬁcant  increase  in  serum  sTREM-1  and  PCT  levels  at the  time  of
admission  (mean  32.99  ± 19.7  ng/ml  and  97.9  ±  86.35  ng/ml,  respectively),  while  patients
with  aseptic  meningitis  showed  (6.8  ±  5.67  ng/ml  and  1.88  ±  1.6 ng/ml,  respectively).
Control  group  showed  sTREM-1  and  PCT  levels  (6.6  ±  4.6 ng/ml  and  0.58  ± 0.36  ng/ml,
respectively)  (P  <  0.05).  sTREM-1  demonstrated  signiﬁcantly  higher  sensitivity  (93.7%)  and
speciﬁcity (94.3%)  in  the  early  prediction  of  sepsis  with  an  area  under  the  receiver  opera-
tor characteristic  (ROC)  curve  (95%  CI)  of  0.94  (0.84–0.99)  at a cut  off value  of 12.4  ng/ml.
Moreover,  sTREM-1  but not  PCT  or  CRP  concentration  was  signiﬁcantly  lower  (P <  0.001)  at
admission  in  patients  with  poor  outcome  than  in  those  with  good  prognosis.
Conclusions: Both  serum  PCT and  sTREM-1  are  valuable  in the early  distinguishing  of septic
from aseptic  meningitis  in children  but  with  markedly  higher  diagnostic  discriminatory
power  for  sTREM-1.  Moreover,  sTREM-1  has  a signiﬁcant  value  in  determining  the  prognosis
of cases  with  septic  meningitis.
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1. Introduction
Acute meningitis in children is mainly aseptic and does
not  require antibiotic treatment [1]. On the other hand, the
mortality  and disabling neurological sequelae from septic
meningitis among children are signiﬁcant making early dif-
ferentiation  between aseptic and septic meningitis cases a
must  [2,3], as early warning signs and symptoms are often
non-speciﬁc, and the routine examination of cerebrospinal
ﬂuid (CSF) and blood is sometimes misleading [4,5]. A rapid
and  reliable test that predicts sepsis, and identify children
at  highest risk with poor ability to start antibiotic treatment
early  improve the outcome [4,6].
These markers include the routine C-reactive protein
(CRP) [7], the powerful and massively studied procalcitonin
(PCT) [2,8–10] as well as the newly proposed, soluble trigg-
ering  receptor expressed on myeloid cells-1 (sTREM-1)
markers [11,12]. CRP, having a molecular mass of 120 kDa
with  a gene location between 1q21 and 1q23, is an impor-
tant  component of innate defense system against infections
[13].  It recognizes the phosphocholine on the surface of
many  bacteria activates the classical complement pathway
and  facilitates phagocytosis by neutrophils. Due to the lack
of  its speciﬁcity, it is used as an additional marker with
more  conventional parameters such as number of leuko-
cytes  in CSF, blood count and protein level to help the
clinician to make a differential diagnosis [14–16].
PCT, the calcitonin precursor propeptide, is a 13 kDa
protein that is synthesized in C cells of the thyroid gland
and  secreted from leukocytes of the peripheral blood [17].
Its  gene is located on the short arm of chromosome 11
(11p15.4) [16]. The secretion of PCT was found to increase
up  to several thousand-fold in the presence of bacterial
sepsis but remains normal or slightly increases in viral
infections and inﬂammatory reactions that are not infec-
tious  [18,19]. In contrast to CRP levels that rise between
12 and 18 h after bacterial challenge [20], serum PCT level
rises  within 2–3 h after infection with a peak value at
6–12  h, and normalizes within 2 days [21]. PCT is stable
in  plasma with plasma half-life of approximately 22 h. It
is  also extremely stable in vitro, unlike most cytokines,
which makes it not only a promising new marker for early
and  sensitive identiﬁcation of infected patients, but also for
titration  of response to the treatment [10,19,22–25]. Still,
PCT  is not considered as a good marker as it can be elevated
in  conditions other than infection, and may  remain low in
infections  [26]. Additionally, interpretation of the studies
dealing with PCT is complicated by variation in the choice
of  the abnormal cut off value, and by the diverse age range
and  nature of the study populations [22].
On the other hand, TREM-1 is a trans-membrane
glycoprotein cell-surface receptor of the immunoglobu-
lin superfamily which acts in cooperation with toll-like
receptors (TLRs) under the control of nuclear factor-
(NF-) [27]. The expression of TREM-1 is up-regulated on
phagocytic cells in the presence of bacteria and fungi, trigg-
ering  the secretion of the pro-inﬂammatory cytokines that
amplify  the host response to these microbial agents [28,29].
As  data demonstrated that expression of membrane-bound
TREM-1 on neutrophils and monocytes/macrophages is
strongly  altered during sepsis, as is the release of its solublend Ultrastructure 1 (2013) 35–42
form  with 6 h peaking, it was highlighted that this protein
may  be useful in the diagnosis of sepsis [27,30].
The aim of this study was to evaluate the diagnos-
tic and prognostic utility of these markers in septic
meningitis and their usefulness in early differentiation
between septic and aseptic meningitis in Egyptian chil-
dren  presenting with signs and symptoms suggestive of
meningitis.
2.  Patients and methods
Children  identiﬁed as possible cases of meningitis
who were admitted to Pediatric Department in Tanta
University Hospital, Tanta, Egypt were included in this
case  control prospective study. Patients were excluded if
they  had received antibiotics in the past seven days or
had  co-existing morbidities. Informed signed consent was
obtained  from parents for their children to participate in
the  study.
All  patients were divided into the following groups:
• Bacterial  meningitis (no = 26): Meningitis was  deﬁned
as septic according to WHO  case deﬁnition criteria [31]:
“children presenting with clinical symptoms of menin-
gitis; fever, headache, stiff neck, bulging fontanelle or
mental status changes, CSF with an elevated protein
(>100 mg/dl), decreased glucose (<40 mg/dl) or leuko-
cytosis (WBC > 100/mm3) with at least 80% neutrophils.
Identiﬁcation of bacteria directly by Gram stain smears or
cultures from blood or CSF or indirectly by latex aggluti-
nation test of CSF” were done.
• Aseptic  meningitis (no = 32): Aseptic meningitis was
deﬁned as the presence of acute onset of meningi-
tis  symptoms, WBC  of > 5/mm3 of which > 50% were
mononuclear/lymphocyte cells with the absence of any
bacterial meningitis laboratory criteria.
• Control  group (no = 15): The control group was deﬁned
by absence of inﬂammatory cells in CSF (WBC < 5/mm3)
and sterile bacteriologic ﬁndings in afebrile children with
positive meningeal signs.
2.1. Protocol
Upon admission, the following items were recorded
for each enrolled patient: age, sex, vital signs as well as
clinical  symptoms and signs. Additionally, blood and CSF
samples  were withdrawn. Blood samples were used for
routine  laboratory investigations including CRP, leukocyte
count  and blood culture, in addition to PCT and sTREM-
1  measurement. CSF samples were examined for protein,
glucose, total and differential WBC. After centrifugation,
the deposits were subjected to Gram stain examination
and microbiological culture. Latex agglutination tests usinggitis.  After 48–72 h of treatment, CRP and serum PCT and
sTREM-1 levels were re-estimated for patients with menin-
gitis  only. Prognosis of cases was followed over a period of
7  days.
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All  patients were subjected to the following investiga-
ions:
. Microbiological cultures: Blood and CSF samples were
collected under complete aseptic conditions according
to the standardized techniques [32]. Microbiological
cultivation  and identiﬁcation with detection of antibi-
ogram of the isolated organisms were carried out in
Microbiology and Immunology Department, Tanta Fac-
ulty of Medicine, Egypt. After aspiration of blood samples
(3–5 ml)  they were subjected to blood cultures (Egyptian
diagnostic media [EDM], Egypt). Blood culture bottles
were incubated at 37 ◦C and examined each 24 h for
turbidity. Subculture from blood culture ﬂasks and cul-
ture of CSF deposits were made on sheep blood agar,
incubated both aerobically and anarobically at 37 ◦C
for 48–72 h and any growth was identiﬁed by colony
morphology, Gram staining and appropriate biochem-
ical reactions were performed according to the standard
microbiological protocol. The performance of antibiotic
sensitivity test and the choice of disks for each iso-
lated organism and the interpretation of zone diameters
results were guided by the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines [33].
.  Serum analysis: Serum was separated from blood sam-
ples collected on admission from all patients and after
2–3 days in patients with meningitis, stored at −20 ◦C,
and used subsequently for assaying CRP, PCT and sTREM-
1.
2.1. C-reactive protein measurement: CRP was measured
using a nephelometric assay (Dade-Behring, France) with
a detection limit of 0.2 mg/l and intra-assay coefﬁcients of
variation at low and high concentrations of 3.3% and 2%,
respectively. The normal value is 6 mg/l.
2.2.  Procalcitonin assay: PCT was measured in dupli-
cate by a speciﬁc immunoluminometric assay (LUMItest®,
Brahms Diagnostica GmbH, Germany), requiring 20 l of
serum and 2 h to complete. Luminescence was measured
automatically on a Berilux Analyzer 250 (Behring Diagnos-
tics, Germany). The detection limit was 0.08 ng/ml, and
the intra-assay coefﬁcients of variation at low and high
concentrations were 12% and 5%, respectively. The normal
serum procalitonin with this is <0.5 ng/ml.
2.3.  Soluble triggering receptor expressed on myeloid
cells-1 ELISA: TREM-1 was measured by commercially
available human ELISA kit according to the manufacturer’s
instructions (Quantikine Human TREM-1 Immunoassay,
R&D Systems, USA), using mouse monoclonal antibody
speciﬁc for human TREM-1 coated on a 96-well plate, 50 l
recombinant human TREM-1 standards and/or samples,
200 l polyclonal antibody against TREM-1 conjugated to
horseradish peroxidase and 200 l TMB  solution contain-
ing tetramethylbenzidine as a substrate. The color was
developed in proportion to the amount of TREM-1 bound,
changed from blue to yellow by the stop solution and
the intensity was measured at 450 nm.  The concentration
of sTREM-1 was then obtained from the standard curve.
The mean minimum detectable dose was 13.8 pg/ml withnd Ultrastructure 1 (2013) 35–42 37
intra-assay variability of 3–7% and inter-assay variability
of 6–8% when measuring in duplicates.
2.3.  Statistical analysis
It  was  performed by using SPSS for Windows, version 9.
Data  were expressed as range and mean ± standard devi-
ation  (SD) or numbers and percentages. Receiver operator
characteristic (ROC) plots were performed using MedCalc
software to determine the areas under the curve (AUCs)
with  95% conﬁdence intervals for the three markers to
predict  septic meningitis. Differences between groups in
continuous variables were tested for signiﬁcance with
the  one way ANOVA and Mann–Whitney tests while uni-
variate analysis was done by Fisher’s exact test. For all
statistical tests done, P value < 0.05 was  considered signif-
icant.
3.  Results
Out of 73 children enrolled in this study, 58 (79.4%)
had a ﬁnal diagnosis of meningitis. They were 34 (58.6%)
males, and 24 (41.3%) females, aged 3 to 156 months
(mean ± SD, 69.3 ± 49.9). Septic meningitis was diagnosed
in  26 (44.85%, mean age ± SD: 63.6 ± 57.36, males vs
females 15:11) and aseptic meningitis in 32 (55.15%, mean
age  ± SD: 69 ± 44, males vs females 19:13). Fifteen chil-
dren  (7 males and 8 females) with age range of 7–154
months (mean ± SD 72.6 ± 51.4) were proven to be non-
meningitis cases and served as controls. All children of
control  group were diagnosed with epilepsy. There was no
difference  between the studied groups in respect to age or
sex  (P > 0.05).
The common manifestations at the time of diagnosis
in the meningitis groups were fever, headache, nausea or
vomiting  and convulsion while in control group were con-
vulsion  and nausea or vomiting (Fig. 1). In the 26 (44.85%)
infected cases of bacteriological origin, 12 (46.15%) were
found  to be Neisseria meningitidis, 8 (30.77%) Haemophilus
inﬂuenza type b and 6 (23%) Streptococcus pneumoniae. The
CSF  Gram staining, CSF culture, CSF soluble antigens and
blood  culture results showed sensitivity of 69.1%, 81.6%,
31.3%  and 26.2%, respectively.
Routine  blood parameters differed signiﬁcantly
between patients with bacterial and aseptic meningitis
(Table 1). WBC  count and ESR level were signiﬁcantly
higher in patients with septic meningitis than patients
with aseptic meningitis and controls at the time of diag-
nosis  (P < 0.05). On the other hand, patients with aseptic
meningitis had signiﬁcantly higher WBC  count (P < 0.05)
than  in control group, but with no signiﬁcant difference
regarding ESR (P > 0.05).
CSF laboratory ﬁndings are shown in Table 2. Patients
with septic meningitis had signiﬁcantly increased CSF pro-
tein,  WBC  count and neutrophil percentage in comparison
with both aseptic meningitis and control groups (P < 0.05),
while  CSF glucose level was signiﬁcantly lower in patients
with  septic meningitis than in patients with aseptic menin-
gitis  (P < 0.05) and controls (P < 0.05).
To determine the role of CRP, PCT and sTREM-1 as diag-
nostic tools in septic meningitis, their levels were evaluated
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Fig. 1. Clinical manifestation of the different studied groups.
Table 1
Comparison of the routine blood and CSF laboratory ﬁndings in the studied groups.
Parameters Bacterial meningitis (no = 26) Aseptic meningitis (no = 32) Control (no = 15) P value
P1 < 0.05*
WBC  (×109/mm3) 16 ± 4.1 8.2 ± 2.1 5.6 ± 2 P2 < 0.05*
P3 < 0.05*
P1 > 0.05
ESR  (mm/h) 32.4 ± 9.7 18 ± 4.99 15.4 ± 3.9 P2 < 0.05*
P3 < 0.05*
Values are mean ± SD (range); WBC, white blood cell count; ESR, erythrocyte sedimentation rate.
P1 Control group vs aseptic meningitis group.
P2 Control group vs septic meningitis group.
P3 Aseptic meningitis group vs septic meningitis group.
* P < 0.05 is signiﬁcant using.
Table 2
Cerebrospinal ﬂuid (CSF laboratory ﬁndings in the studied groups.
Bacterial meningitis group (no = 26) Aseptic meningitis group (no = 32) Control group (no = 15) P value
P1 > 0.05
Protein  (mg/dl) 162.19 ± 37.5 38.1 ± 10.25 32.8 ± 6.78 P2 < 0.05*
P3 < 0.05*
P1 > 0.05
Glucose  (mg/dl) 25.6 ± 8.4 51.5 ± 11.68 53.6 ± 13.3 P2 < 0.05*
P3 < 0.05*
P1 < 0.05*
WBC  (/mm3) 297.46 ± 107.6 104.28 ± 26.72 0.0 ± 0.0 P2 < 0.05*
P3 < 0.05*
P1 < 0.05*
Neutrophil (%) 84 ± 2.6 15 ± 2 0.0 ± 0.0 P2 < 0.05*
P3 < 0.05*
Values are mean ± SD (range); WBC, white blood cell count; ESR, erythrocyte sedimentation rate.
P1 Control group vs aseptic meningitis group.
P2 Control group vs septic meningitis group.
P3 Aseptic meningitis group vs septic meningitis group.
* P < 0.05 is signiﬁcant.
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Table 3
Comparison of CRP, PCT and sTREM serum levels on admission between the different studied groups.
Septic meningitis group (no = 26) Aseptic meningitis group (no = 32) Control group (no = 15) P value
P1 < 0.05*
CRP (mg/l) 126 ± 90.5 35 ± 25.38 15 ± 9 P2 < 0.05*
P3 < 0.05*
P1 > 0.05
PCT (ng/ml) 97.9  ± 86.35 1.88 ± 1.6 0.58 ± 0.36 P2 < 0.05*
P3 < 0.05*
P1 > 0.05
sTREM-1 (ng/ml) 32.99 ± 19.79 6.8 ± 5.67 6.6 ± 4.6 P2 < 0.05*
P3 < 0.05*
Values are mean ± SD (range); WBC, white blood cell count; ESR, erythrocyte sedimentation rate.
P1 Control group vs aseptic meningitis group.
P2 Control group vs septic meningitis group.
P3 Aseptic meningitis group vs septic meningitis group.
* P < 0.05 is signiﬁcant.
Fig. 2. Receiver operating characteristic (ROC) curves comparing admis-
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ratory information such as CBC, neutrophil count, and
CRP  concentration with up to 40% possibility of overlapion, CRP, PCT and sTREM-1 for prediction of septic meningitis.
n admission. Baseline CRP, PCT and sTREM-1 levels were
igniﬁcantly higher in patients with septic meningitis than
n  patients with aseptic meningitis and control groups
P  < 0.05). On the other hand, patients with aseptic menin-
itis  had signiﬁcantly higher CRP value (P < 0.05) than in
ontrol  group, but with no signiﬁcant difference regarding
erum PCT and sTREM-1 levels (P > 0.05) (Table 3). Although
heir  levels were signiﬁcantly decreased (P < 0.05) after
8–72  h of treatment in patients with septic meningitis,
RP, PCT and sTREM-1 values were still signiﬁcantly higher
P  < 0.05) than in patients with aseptic meningitis.
Plasma sTREM-1 levels at admission were
2.99 ± 19.79 ng/ml in septic meningitis cases and
.8  ± 5.67 ng/ml in aseptic meningitis cases. As shown
n  Fig. 2, plasma sTREM-1 levels yielded the highest
iscriminative value with area under the ROC curve being
.94  (95% CI, 0.84–0.99). Although this value did not
how statistical signiﬁcance when compared with 0.92 of
CT  (95% CI, 0.81–0.98; P > 0.05), the difference became
igniﬁcantly evident for 0.87 of CRP (95% CI, 0.75–0.95;
 = 0.03).
The sensitivity, speciﬁcity, and positive and negative
redictive values of CRP, PCT and sTREM-1 are shown in
Table  4). At a cutoff of 12.4 ng/ml, sTREM-1 yielded a sen-
itivity  of 93.7% and a speciﬁcity of 94.3% in differentiating
atients with septic from those with aseptic meningitis. Of
otice,  the use of combination of sTREM-1 and PCT did notaffect  the sensitivity but increased the speciﬁcity to 97.1%
with  no improvement when CRP values were added.
Comparison of CRP, PCT and sTREM-1 serum levels at
admission and after 48–72 h in and between patients with
aseptic  and bacterial meningitis is shown in Table 5. After
48  h, there was  no signiﬁcant difference in CRP (P = 0.058),
PCT  (P = 0.16) and sTREM-1 (P = 0.09) levels compared to
their  levels at admission in aseptic group. In contrary, CRP
(P  < 0.001), PCT (P = 0.01) and sTREM-1 (P = 0.002) values
were signiﬁcantly reduced 48–72 h after admission com-
pared  to their baseline values in septic group. The level of
these  markers were signiﬁcantly higher in septic than non-
septic  group after 48–72 h (CRP: P = 0.016, PCT: P < 0.001
and  sTREM-1: P < 0.001).
Fig. 2 shows the receiver operating characteristic (ROC)
curves comparing admission, C-reactive protein (CRP), pro-
calcitonin  (PCT) and soluble triggering receptor expressed
on  myeloid cells-1 (sTREM-1) for prediction of septic
meningitis. The area under the curve (95% CI) was  0.87
(0.75–0.95) for CRP, 0.92 (0.81–0.98) for PCT and 0.94
(0.84–0.99) for sTREM-1.
The  use of the current parameters as prognostic
markers was  also evaluated. Seven (26.9%) of 26 patients
with septic meningitis showed poor outcome and died.
Serum  sTREM-1 level [10 ± 7.4 ng/ml vs 41.4 ± 15.6 ng/ml,
Z  = 2.7; P < 0.001) but not PCT [120.97 ± 81.64 ng/ml
vs 99.97 ± 88 ng/ml, Z = 1.13, P = 0.58) or CRP lev-
els [114 ± 48.84 ng/ml vs 130 ± 102.49 ng/ml, Z = 0.17,
P  = 0.69). Noticeably, the AUCs of ROC for CRP, PCT and
sTREM-1 in predicting septic meningitis poor outcome
were 0.53 (95% CI 0.42–0.61), 0.62 (95% CI 0.58–0.71) and
0.87  (95% CI 0.78–0.92), respectively.
4. Discussion
Diagnosis of septic meningitis is the milestone in pre-
venting unnecessary antibiotic and hospital admission
in one hand and serious neurological damage or even
death in the other. Management strategies have oriented
toward the use of combination of clinical and labo-between septic and aseptic cases [34]. Intensive researches
have been carried out to ﬁnd new accurate, rapid, and
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Table 4
Sensitivity, speciﬁcity, positive and negative predictive values (%) of admission CRP, PCT and sTREM values for septic meningitis.
Marker Cut off value Sensitivity % (95% CI) Speciﬁcity % (95% CI) PPV % (95% CI) NPV % (95% CI)
CRP >29 mg/l 81.2 (54.4–96) 80 (63.1–91.6) 68.4 (62–71) 90.6 (88–95)
PCT  >3.3 ng/ml 87.5 (61.7–98.4) 88.6 (73.3–96.8) 82.4 (77–85) 94.1 (89–95)
sTREM-1 >12.4 ng/ml 93.7 (69.8–99.8) 94.3 (80.8–99.3) 88.2 (84–93) 97.1 (91–99)
Optimum diagnostic cut off values derived from the ROC curve. CRP, C-reactive protein; PCT, procalcitonin; sTREM-1, soluble triggering receptor expressed
on  myeloid cells-1; CI, conﬁdence interval; AUC of ROC, area under curve of the receiver operating characteristics curves; PPV, positive predictive value;
NPV,  negative predictive value.
Table 5
Comparison of CRP, PCT and sTREM-1 serum levels at admission and after 48–72 h in and among patients with aseptic and bacterial meningitis.
Septic meningitis (no = 26) Aseptic meningitis (no = 32)
On admission After 48–72 h On admission After 48–72 h
CRP (mg/l) 126 ± 90.5 51 ± 42.6 35 ± 25.38 25.4 ± 19
P1  < 0.001* P2 = 0.058 P3 = 0.016*
PCT (ng/ml) 97.9 ± 86.35 45.1 ± 36.8 1.88 ± 1.6 1.42 ± 1.3
P1  = 0.01* P2 = 0.163 P3 < 0.001*
sTREM-1 (ng/ml) 32.99 ± 19.79 17.69 ± 13.5 6.8  ± 5.67 4.65 ± 3.8
P1  = 0.002* P2 = 0.09 P3 < 0.001*
P1: Septic meningitis on admission vs bacterial meningitis after 48–72 h.
P2:  Aseptic meningitis on admission vs aseptic meningitis after 48–72 h.
P3:  Septic meningitis after 48–72 h vs aseptic meningitis after 48–72 h.
* P < 0.05 is signiﬁcant using t-test and Mann–Whitney Rank Sum Test.
reliable diagnostic methods to differentiate between bac-
terial  and viral meningitis with a varying degree of success
and  only few of them reported in children [35]. Therefore,
this work aimed to evaluate the use of sTREM in compari-
son to PCT and CRP in early diagnosis and differentiation
between septic and aseptic meningitis cases in Egyp-
tian children with evaluation of their role as prognostic
markers.
Procalcitonin was initially described as a potential
marker of bacterial diseases by Assicot et al. [36] and
assumed to be a protein of the acute phase of inﬂamma-
tion with kinetics faster than that of CRP [21]. Indeed, the
current  hypothesis on this marker in sepsis has gained a
solid  scientiﬁc basis as many researches demonstrated that
quantitative evaluation of PCT is superior to the other used
biomarkers, can markedly reduce antibiotic usage and as
being  a hormokine mediator, immunoneutralisation of it
might  offer new hope for more effective treatment options
[12,24–26].
However, on reviewing the results of different studies
carried out all over the world to evaluate PCT discrimina-
tive ability in detecting septic meningitis, controversial was
clear.  Prasad et al. [37] found that, serum PCT level was  sig-
niﬁcantly  higher in children with septic meningitis than
in  those with aseptic meningitis or in controls and it may
be  used to differentiate between septic and aseptic menin-
gitis.  Another Egyptian study by Ibrahim et al. [38] who
reported that, serum PCT levels were signiﬁcantly higher
in  bacterial meningitis (BM) compared with non bacterial
meningitis. There is a positive correlation between serum
PCT,  TLC and CRP in bacterial and non-bacterial meningi-
tis  cases but this relation becomes highly signiﬁcant with
bacterial meningitis positive group. After 3–6 days of treat-
ment  serum PCT was signiﬁcantly lower than on admission
levels. Therefore, serum procalcitonin has a better diagnos-
tic  and prognostic value to differentiate between bacterialand  aseptic meningitis. It is also a good indicator of the
efﬁcacy of treatment of bacterial meningitis [39].
This was supported by the British study of Hatherill et al.
[22]  who  revealed high discriminative power of serum PCT
with  AUC of 0.93. In the Slovenia study by Jereb et al. [40] a
sensitivity  of 90% and a speciﬁcity of 100% for the diagno-
sis  of bacterial meningitis or encephalitis, using a decision
threshold of 0.5 ng/ml for serum PCT was obtained. On
contrary, Hoffmann et al. [41] reported normal PCT serum
concentrations in 12 adults suffering from bacterial menin-
gitis,  where PCT on admission was ≤0.5 ng/ml. In another
German study of Schwarz et al. [8] neither the sensitivity
nor the speciﬁcity of the test using the PCT were signiﬁ-
cantly better than those using the CRP test. On the regional
level, an African study led by Carrol et al. [12] concluded
that PCT is the best diagnostic and prognostic marker of
sever  bacterial sepsis in Malawian children, including those
with  septic meningitis.
This  work supported the role of serum PCT mea-
surement in early distinguishing of septic from aseptic
meningitis with 87.5% sensitivity and 88.6% speciﬁcity at
admission  PCT cut off value of 3.3 ng/ml. Although the
performance of PCT was nearly similar to that of CRP in
predicting sepsis, the rapid kinetics and the more speci-
ﬁcity  of PCT made it superior to CRP in that aspect. It is
important to notify that the increase of PCT and CRP in
bacterial meningitis is due to extracellular multiplication in
the  bloodstream which induce a strong systemic inﬂamma-
tory  response [42]. This is supported by the study of Jereb
et  al. [40] where two cases of bacterial meningitis with low
serum  PCT occurred due to non-encapsulated bacteria that
multiply  intracellularly, these were proved to be caused by
borreliosis  and tuberculosis.
The  speciﬁc involvement of TREM-1 solely in cases
of infection has led researchers to investigate the diag-
nostic value of plasma sTREM-1 assay in distinguishing
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epsis from severe systemic non-infectious inﬂammation
mong newly admitted critically ill patients with suspected
nfection [30]. Although baseline plasma levels of CRP, PCT
nd  sTREM-1 were higher among septic patients than in
atients  with systemic inﬂammatory response syndrome,
nly serum sTREM-1 levels appeared to be the most helpful
arameter in differentiating between them. Unfortunately,
ittle is known about the role of sTREM in meningitis [43].
arrol  et al. [12] in their comparative study of accuracy of
ve  markers in the diagnosis of serious bacterial infections
SBI) including meningitis concluded that PCT not sTREM-
,  was the best diagnostic and prognostic marker in SBI
hile  PCT and CD163 was superior to the other markers
n  predicting fatal outcome. On attempting to evaluate the
iagnostic  role of measuring sTREM-1 in CSF, unlike PCT,
TREM-1 was concluded to be unregulated in the CSF of
atients  with bacterial meningitis [44,45].
So, one of our main goals in this work was to evalu-
te the role of measuring serum sTREM-1 levels as an easy
nd  non invasive procedure in early differentiating of septic
rom  aseptic meningitis. Similar to PCT but with markedly
igher diagnostic discriminatory power, serum sTREM-1
howed signiﬁcantly higher concentrations early in septic
eningitis compared to patients with aseptic meningitis
nd controls which was not the case in patients with asep-
ic  meningitis when compared with the control group. After
8–72  h of treatment, patients with septic meningitis still
ad  high serum PCT but signiﬁcantly decreased in compar-
son  with the admission levels.
With agreement to our study, Su et al. [46] reported that,
n  ICU day 1, the sepsis group had higher serum sTREM-1,
CT, and CRP levels compared with non-infectious systemic
nﬂammatory response syndrome (SIRS) group. The previ-
us  report was also supported by the recent Japanese study
f  Oku et al. [47].
Unlike  PCT and CRP, soluble TREM-1 concentration
as signiﬁcantly low at admission in patients with poor
utcome with neatly stationary value after 48–72 h. Addi-
ionally, the low baseline sTREM-1 level was found to
e  the best prognostic factor of the poor outcome with
he  highest AUC value denoting in other word that ele-
ated  baseline sTREM-1 level could be a valuable protective
arker. Interestingly, the mechanism by which sTREM
odulate the immune response is still unclear however
n  a mouse model, blockade sTREM-1 signaling reduced
ut  did not abolish NF-B activation and cytokine pro-
uction through competing with the natural ligand of
REM-1  and/or impairing TREM-1 dimerization, thus pro-
ecting  septic animals from hyper-responsiveness and
eath  [11,48].
In  conclusion, both serum PCT and sTREM are valuable
n  early distinguishing of septic from aseptic meningitis
n children but with markedly higher diagnostic discrim-
natory power for sTREM-1. Moreover, this study pointed
o  the signiﬁcant value of sTREM-1 in determining septic
eningitis prognosis. However, it remains to be conﬁrmed
n  larger populations.onﬂict of interest
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